ERBB2 and neoplasm: Liquid biopsy, a recent technique which allows identification of fragments of tumor cells or DNA circulating in the blood [7,8] has replaced tissue biopsy for detection of gene mutations; however, the latter method remains fundamental to reassessing HR and HER2 status.